FDA Adverse Event Injury Summary report: N

CARDELLA¿ PULMONARY ARTERY SENSOR SYSTEM

MDR report key: 23108763 · Received September 22, 2025

Report

Report Number
3024985933-2025-00031
Event Type
Injury
Date Received
September 22, 2025
Date of Event
August 29, 2025
Report Date
January 16, 2026
Manufacturer
ENDOTRONIX, INC
Product Code
MOM
PMA / PMN Number
P230040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING SECTIONS WERE UPDATED/CORRECTED/ADDED: A2, A3, A4, B5, B4, G3, G6, H1, H2, H6, & H11. H2 - EVALUATION SUMMARY: THE SENSOR WAS NOT RETURNED FOR EVALUATION AS IT REMAINED IMPLANTED IN THE PATIENT. THE DEVICE HISTORY RECORD (DHR) FOR THE SENSOR LOT WAS REVIEWED, NO RELEVANT NONCONFORMANCES WERE ASSOCIATED WITH THE SENSOR LOT AT THE TIME OF MANUFACTURE WERE IDENTIFIED. FOLLOWING REVIEW OF PATIENT/SENSOR DATA, RECALIBRATION WAS RECOMMENDED ON 15-DEC-2025. THE PATIENT UNDERWENT A RIGHT HEART CATHETERIZATION WITH SENSOR RECALIBRATION. THE SENSOR WAS CONFIRMED TO BE FUNCTIONING AS INTENDED. BASED ON THE INFORMATION PROVIDED, NO FURTHER CORRECTIVE OR PREVENTATIVE ACTIONS ARE REQUIRED AT THIS TIME.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION WILL BE SUBMITTED VIA FOLLOW-UP REPORT WITHIN 30 DAYS OF RECEIPT.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE PATIENT UNDERWENT A RIGHT HEAT CATHETERIZATION OF THE SENSOR (B)(6) 2025. THE SENSOR WAS CONFIRMED TO BE PERFORMING AS INTENDED.

Description of Event or Problem · 0

THE PATIENT'S DATA WAS REVIEWED BY ENDOTRONIX'S INTERNAL MONITORING PROGRAM AND SUSPECTED SENSOR INACCURACY WAS IDENTIFIED. THE SITE HAS BEEN INFORMED TO SCHEDULE A RECALIBRATION. THE PATIENT IS CURRENTLY PENDING A RIGHT HEART CATHETERIZATION (RHC) AND SENSOR RECALIBRATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2535118 CARDELLA¿ PULMONARY ARTERY SENSOR SYSTEM PULMONARY ARTERY SENSOR MOM ENDOTRONIX, INC T100303-04 E200902-02

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown